Mindfulness Meditation in Glioma Patients

NACompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

April 11, 2019

Primary Completion Date

January 9, 2020

Study Completion Date

January 9, 2020

Conditions
Malignant Glioma
Interventions
BEHAVIORAL

Mindfulness meditation

The study intervention consists of seven mindfulness sessions (six 1-hour telephone sessions and one 1-hour in-person session). The six weekly telephone-based mindfulness sessions will occur in a one-on-one format and will be followed by one in-person, one-on-one session, which will occur at the post-chemoradiation standard of care clinic visit.

Trial Locations (1)

27710

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Duke Cancer Institute

OTHER

lead

Duke University

OTHER

NCT03915912 - Mindfulness Meditation in Glioma Patients | Biotech Hunter | Biotech Hunter